pI: 8.5387 |
Length (AA): 3043 |
MW (Da): 337095 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
105 | 1100 | 1u6g (C) | 12 | 1069 | 10.00 | 0 | 0.97 | 0.286909 | 0.71 |
662 | 998 | 4rxh (B) | 177 | 507 | 12.00 | 0.000093 | 0.39 | 0.221846 | -0.64 |
2625 | 3035 | 3g1n (B) | 3996 | 4366 | 31.00 | 0 | 1 | 0.342364 | 0.16 |
2851 | 3037 | 5hps (A) | 735 | 917 | 32.00 | 0 | 1 | 0.355053 | 0.12 |
2940 | 3033 | 3pt3 (A) | 2703 | 2791 | 34.00 | 0 | 0.9 | 0.230491 | -0.82 |
2949 | 3033 | 3pt3 (A) | 2712 | 2791 | 40.00 | 0.079 | 0.86 | 0.304233 | -0.57 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128439)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G02880 | E3 ubiquitin-protein ligase UPL4 |
Arabidopsis thaliana | AT4G38600 | HECT ubiquitin protein ligase family protein |
Babesia bovis | BBOV_IV000570 | ubiquitin transferase, HECT domain containing protein |
Brugia malayi | Bm1_16175 | thyroid receptor interacting protein 12 |
Candida albicans | CaO19.3237 | similar to S. cerevisiae UFD4 (YKL010C) ubiquitin--protein ligase |
Candida albicans | CaO19.10747 | similar to S. cerevisiae UFD4 (YKL010C) ubiquitin--protein ligase |
Dictyostelium discoideum | DDB_G0287221 | armadillo repeat-containing protein |
Drosophila melanogaster | Dmel_CG42574 | circadian trip |
Echinococcus granulosus | EgrG_000106000 | E3 ubiquitin protein ligase TRIP12 |
Echinococcus multilocularis | EmuJ_000106000 | E3 ubiquitin protein ligase TRIP12 |
Homo sapiens | ENSG00000153827 | thyroid hormone receptor interactor 12 |
Leishmania braziliensis | LbrM.32.1190 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_321150.1 | HECT-domain (ubiquitin-transferase), putative |
Leishmania infantum | LinJ.32.1150 | hypothetical protein, conserved |
Leishmania major | LmjF.32.1090 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.31.1090 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05367 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14322 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11488 | thyroid hormone receptor interactor 12 |
Mus musculus | ENSMUSG00000026219 | thyroid hormone receptor interactor 12 |
Oryza sativa | 4339037 | Os05g0463900 |
Oryza sativa | 4327983 | Os02g0101700 |
Oryza sativa | 4337658 | Os05g0122400 |
Saccharomyces cerevisiae | YKL010C | putative ubiquitin-protein ligase UFD4 |
Schistosoma japonicum | Sjp_0131350 | expressed protein |
Schistosoma japonicum | Sjp_0063470 | E3 ubiquitin-protein ligase UPL3, putative |
Schistosoma mansoni | Smp_172420 | ubiquitin protein ligase E3a |
Schmidtea mediterranea | mk4.004160.03 | |
Schmidtea mediterranea | mk4.000217.04 | |
Schmidtea mediterranea | mk4.016586.01 | |
Schmidtea mediterranea | mk4.014585.00 | |
Schmidtea mediterranea | mk4.000514.00 | |
Trypanosoma brucei gambiense | Tbg972.11.16050 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.14330 | HECT-domain (ubiquitin-transferase), putative |
Trypanosoma congolense | TcIL3000.11.14630 | Zinc finger, ZZ type, putative |
Trypanosoma cruzi | TcCLB.511725.160 | HECT-domain (ubiquitin-transferase), putative |
Theileria parva | TP01_0078 | hypothetical protein |
Trichomonas vaginalis | TVAG_056400 | hect E3 ubiquitin ligase, putative |
Trichomonas vaginalis | TVAG_248540 | ubiquitin protein ligase E3a, putative |
Trichomonas vaginalis | TVAG_201990 | ubiquitin protein ligase E3a, putative |
Trichomonas vaginalis | TVAG_269910 | ubiquitin protein ligase E3a, putative |
Trichomonas vaginalis | TVAG_248520 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_119130 | ubiquitin protein ligase E3a, putative |
Trichomonas vaginalis | TVAG_063800 | ubiquitin protein ligase E3a, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.5930 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5930 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5930 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5930 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.